Feb 23, 2022 / 05:30PM GMT
Joanne Karen Wuensch - Citigroup Inc., Research Division - MD
Good afternoon, everybody, or good morning or good evening, depending on where you are. My name is Joanne Wuensch. I'm the U.S. medical technology analyst. Very pleased to have with us today CEO, Mick Farrell from ResMed. As many of you know, ResMed is covered by our Australian analyst John Deakin-Bell. Today, I'm the moderator. So let's just get started.
Questions and Answers:
Joanne Karen Wuensch - Citigroup Inc., Research Division - MDMick, the industry is dominated - commentary, at least - is dominated currently by the Philips device recall. In John's memory, this is about a 3.5 million units, which are recalled, and a key question to start off this discussion is how are the customers coping? And how are the physicians coping with this impact?
Michael J. Farrell - ResMed Inc. - CEO & Director
Yes. Well, I believe the latest data, Joanne, is -- John was right about 2 months ago. I think our competitor updated it to 5.2 million devices that